SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

Morgan Stanley Maintains Equal-Weight on Accolade, Raises Price Target to $12

Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and raises the price target from $9 to $12.

Benzinga · 09/14/2022 07:29
Morgan Stanley analyst Ricky Goldwasser maintains Accolade (NASDAQ:ACCD) with a Equal-Weight and raises the price target from $9 to $12.